Roger J. Waltzman insider trades

Open-market stock purchases and sales by Roger J. Waltzman, Chief Medical Officer at Indaptus Therapeutics, Inc, from SEC Form 4 filings since Aug 12, 2016.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • INDP Indaptus Therapeutics, Inc: other filings, last Oct 9, 2024
  • MTEM Molecular Templates, Inc: other filings, last Feb 15, 2023
  • JAGX Jaguar Animal Health, Inc: other filings, last Dec 19, 2016

Get free alerts when Roger J. Waltzman files a new trade →